Use of Electronic Health Record Data for Drug Safety Signal Identification: A Scoping Review
Authors:
- 20 June 2023
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 46 (8) , 725-742
Abstract
Introduction Pharmacovigilance programs protect patient health and safety by identifying adverse event signals through postmarketing surveillance of claims data and spontaneous reports. Electronic health records (EHRs) provide new opportunities to address limitations of traditional approaches and promote discovery-oriented pharmacovigilance. Methods To evaluate the current state of EHR-based medication safety signal identification, we conducted a scoping literature review of studies aimed at identifying safety signals from routinely collected patient-level EHR data. We extracted information on study design, EHR data elements utilized, analytic methods employed, drugs and outcomes evaluated, and key statistical and data analysis choices. Results We identified 81 eligible studies. Disproportionality methods were the predominant analytic approach, followed by data mining and regression. Variability in study design makes direct comparisons difficult. Studies varied widely in terms of data, confounding adjustment, and statistical considerations. Conclusion Despite broad interest in utilizing EHRs for safety signal identification, current efforts fail to leverage the full breadth and depth of available data or to rigorously control for confounding. The development of best practices and application of common data models would promote the expansion of EHR-based pharmacovigilance.Keywords
Funding Information
- U.S. Food and Drug Administration (75F40119D10037, 7540119F19002)
This publication has 103 references indexed in Scilit:
- Using text‐mining techniques in electronic patient records to identify ADRs from medicine useBritish Journal of Clinical Pharmacology, 2012
- Data-Driven Prediction of Drug Effects and InteractionsScience Translational Medicine, 2012
- A novel algorithm for detection of adverse drug reaction signals using a hospital electronic medical record databasePharmacoepidemiology and Drug Safety, 2011
- Antidiabetic treatments and risk of hospitalisation with myocardial infarction: a nationwide case–control studyPharmacoepidemiology and Drug Safety, 2011
- Combining electronic healthcare databases in Europe to allow for large‐scale drug safety monitoring: the EU‐ADR ProjectPharmacoepidemiology and Drug Safety, 2010
- Rapid Identification of Myocardial Infarction Risk Associated With Diabetes Medications Using Electronic Medical RecordsDiabetes Care, 2009
- Active Computerized Pharmacovigilance Using Natural Language Processing, Statistics, and Electronic Health Records: A Feasibility StudyJournal of the American Medical Informatics Association, 2009
- Defining ‘Signal’ and its Subtypes in Pharmacovigilance Based on a Systematic Review of Previous DefinitionsDrug Safety, 2009
- Detecting Adverse Events Using Information TechnologyJournal of the American Medical Informatics Association, 2003
- Use of the UK General Practice Research Database for pharmacoepidemiologyBritish Journal of Clinical Pharmacology, 1998